{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T15:59:42Z","timestamp":1786118382819,"version":"build-2736575974"},"reference-count":30,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T00:00:00Z","timestamp":1785974400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To assess the associations of the systemic immune-inflammation index (SII) and small dense low-density lipoprotein cholesterol (sdLDL-C) with 1-year major adverse cardiovascular events (MACE) in patients with unstable angina pectoris (UAP) and to evaluate their individual and combined discriminative performance.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      This single-center retrospective cohort study included 157 patients diagnosed with UAP who underwent coronary angiography between January 2022 and June 2024. Routine blood counts, lipid profiles, and electrocardiography were obtained within 24\u2005h after admission. SII was calculated as neutrophil count \u2009\u00d7\u2009 platelet count\/lymphocyte count. The prespecified endpoint was the occurrence of at least one MACE during the fixed 1-year follow-up period, including cardiac death, nonfatal myocardial infarction, target vessel revascularization, or rehospitalization for worsening heart failure. Patients were classified into the MACE group (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200938) and the non-MACE group (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u2009119). Variables showing statistical significance in the univariable analyses were entered into a multivariable logistic regression model to identify factors independently associated with 1-year MACE. Receiver operating characteristic curves were used to assess the discriminative performance of SII, sdLDL-C, and their combination. Internal validation was performed using 1,000 bootstrap resamples.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Compared with the non-MACE group, patients in the MACE group were older, had a higher prevalence of diabetes mellitus, higher Gensini scores, and more frequent multi-lead ischemic changes on electrocardiography. The MACE group also had higher WBC, NEUT, PLT, SII, TG, and sdLDL-C levels and lower LYM levels (all\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&amp;lt;\u20090.05). Multivariable logistic regression showed that SII\u2009\u2265\u20091,100 (OR\u2009=\u20093.58, 95% CI: 1.79\u20137.14;\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&amp;lt;\u20090.001), sdLDL-C\u2009\u2265\u20091.02\u2005mmol\/L (OR\u2009=\u20092.91, 95% CI: 1.42\u20135.97;\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.003), Gensini score\u2009\u2265\u200945 points (OR\u2009=\u20092.67, 95% CI: 1.31\u20135.46;\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.006), and multi-lead ischemic changes (OR\u2009=\u20092.43, 95% CI: 1.18\u20135.01;\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.017) were independently associated with 1-year MACE. The AUCs of SII, sdLDL-C, and the combined SII\u2013sdLDL-C model were 0.832, 0.789, and 0.914, respectively. After bootstrap validation, the optimism-corrected AUC of the combined model was 0.893, with a calibration slope of 0.87.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Elevated SII and sdLDL-C levels were independently associated with MACE within 1 year in patients with UAP. Their combination showed better discrimination than either marker alone. However, because of the limited number of patients with MACE and the absence of external validation, these findings should be considered exploratory and require confirmation in larger prospective multicenter cohorts.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fcvm.2026.1840437","type":"journal-article","created":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T15:38:21Z","timestamp":1786030701000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Combined discriminative value of SII and sdLDL-C for 1-year major adverse cardiovascular events in patients with unstable angina pectoris"],"prefix":"10.3389","volume":"13","author":[{"given":"Qian","family":"Zhao","sequence":"first","affiliation":[{"name":"Department of Cardiovascular Medicine, Central Hospital Affiliated to Shandong First Medical University, Jinan Central Hospital","place":["Jinan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Peng","sequence":"additional","affiliation":[{"name":"Electrocardiogram (ECG) Room, Special Examination Department, Jinan Eighth People's Hospital","place":["Jinan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Li","sequence":"additional","affiliation":[{"name":"Henan Medical University","place":["Xinxiang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,8,6]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"100655","DOI":"10.1016\/j.cpcardiol.2020.100655","article-title":"Obesity and coronary heart disease: epidemiology, pathology, and coronary artery imaging","volume":"46","author":"Katta","year":"2021","journal-title":"Curr Probl Cardiol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"100","DOI":"10.31083\/j.fbl2703100","article-title":"Alterations in the fecal microbiota and serum metabolome in unstable angina pectoris patients","volume":"27","author":"Liu","year":"2022","journal-title":"Front Biosci (Landmark Ed)"},{"key":"B3","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.amjcard.2021.12.044","article-title":"Unstable angina pectoris with myocardial injury versus myocardial infarction in the era of high-sensitivity cardiac troponin","volume":"169","author":"Roos","year":"2022","journal-title":"Am J Cardiol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1038\/s41392-022-00955-7","article-title":"Inflammation and atherosclerosis: signaling pathways and therapeutic intervention","volume":"7","author":"Kong","year":"2022","journal-title":"Signal Transduct Target Ther"},{"key":"B5","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1038\/s41419-024-07166-8","article-title":"Inflammation in atherosclerosis: pathophysiology and mechanisms","volume":"15","author":"Ajoolabady","year":"2024","journal-title":"Cell Death Dis"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.3390\/nu15051177","article-title":"Association between systemic immunity-inflammation Index and hyperlipidemia: a population-based study from the NHANES (2015\u20132020)","volume":"15","author":"Mahemuti","year":"2023","journal-title":"Nutrients"},{"key":"B7","doi-asserted-by":"publisher","first-page":"9553","DOI":"10.3390\/ijms23179553","article-title":"Investigation of the associations of novel inflammatory biomarkers-systemic inflammatory Index (SII) and systemic inflammatory response Index (SIRI)-with the severity of coronary artery disease and acute coronary syndrome occurrence","volume":"23","author":"Dziedzic","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B8","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1016\/j.pcad.2020.04.009","article-title":"Small dense low-density lipoprotein-cholesterol (sdLDL-C): analysis, effects on cardiovascular endpoints and dietary strategies","volume":"63","author":"Santos","year":"2020","journal-title":"Prog Cardiovasc Dis"},{"key":"B9","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1186\/s12872-025-04871-w","article-title":"Association of sdLDL-C\/LDL-C ratio with atherosclerotic cardiovascular disease: a case-control study","volume":"25","author":"Yang","year":"2025","journal-title":"BMC Cardiovasc Disord"},{"key":"B10","doi-asserted-by":"publisher","first-page":"e20240265","DOI":"10.36660\/abc.20240265","article-title":"Association between estimated small dense low-density lipoprotein-cholesterol (sdLDL-C) and atherosclerotic cardiovascular disease risk","volume":"122","author":"Zhang","year":"2025","journal-title":"Arq Bras Cardiol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"113633","DOI":"10.1016\/j.jconrel.2025.113633","article-title":"Shear force and cholesterol affinity responsive drug delivery system for treating inflammation and abnormal lipid metabolism in atherosclerosis","volume":"381","author":"Zhang","year":"2025","journal-title":"J Control Release"},{"key":"B12","doi-asserted-by":"publisher","first-page":"117768","DOI":"10.1016\/j.jep.2024.117768","article-title":"An ethanolic extract of Arctium lappa L. Leaves ameliorates experimental atherosclerosis by modulating lipid metabolism and inflammatory responses through PI3\u2005K\/akt and NF-\u03baB singnaling pathways","volume":"325","author":"Guo","year":"2024","journal-title":"J Ethnopharmacol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s00059-023-05222-1","article-title":"Management of acute coronary syndrome: eSC guidelines 2023","volume":"49","author":"Buske","year":"2024","journal-title":"Herz"},{"key":"B14","doi-asserted-by":"publisher","first-page":"187","DOI":"10.2147\/IJGM.S384626","article-title":"Gensini Score's Severity and its relationship with risk factors for coronary artery disease among patients who underwent angiography in Somalia's Largest PCI centre","volume":"17","author":"Aksu","year":"2024","journal-title":"Int J Gen Med"},{"key":"B15","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1177\/17534259231189195","article-title":"Role of neutrophils in different stages of atherosclerosis","volume":"29","author":"Zhang","year":"2023","journal-title":"Innate Immun"},{"key":"B16","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1111\/joim.13794","article-title":"Platelets as an inter-player between hyperlipidaemia and atherosclerosis","volume":"296","author":"Li","year":"2024","journal-title":"J Intern Med"},{"key":"B17","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1016\/j.tibs.2024.06.003","article-title":"Immunometabolism in atherosclerosis: a new understanding of an old disease","volume":"49","author":"Certo","year":"2024","journal-title":"Trends Biochem Sci"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1087345","DOI":"10.3389\/fimmu.2023.1087345","article-title":"Association of systemic immune inflammatory index with all-cause and cause-specific mortality in hypertensive individuals: results from NHANES","volume":"14","author":"Cao","year":"2023","journal-title":"Front Immunol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"2862","DOI":"10.3390\/diagnostics15222862","article-title":"Evaluating immune-inflammatory indices for risk stratification in cardiovascular disease: an Umbrella review of systematic reviews and meta-analyses","volume":"15","author":"Liu","year":"2025","journal-title":"Diagnostics (Basel)"},{"key":"B20","doi-asserted-by":"publisher","first-page":"e13230","DOI":"10.1111\/eci.13230","article-title":"Systemic immune-inflammation index (SII) predicted clinical outcome in patients with coronary artery disease","volume":"50","author":"Yang","year":"2020","journal-title":"Eur J Clin Invest"},{"key":"B21","doi-asserted-by":"publisher","first-page":"931931","DOI":"10.3389\/fphys.2022.931931","article-title":"Low-density lipoprotein particles in atherosclerosis","volume":"13","author":"Qiao","year":"2022","journal-title":"Front Physiol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"2122","DOI":"10.1016\/j.jacc.2020.02.059","article-title":"Triglyceride-Rich lipoprotein cholesterol, small dense LDL cholesterol, and incident cardiovascular disease","volume":"75","author":"Duran","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"2897","DOI":"10.3390\/biomedicines11112897","article-title":"Oxidative stress, atherogenic dyslipidemia, and cardiovascular risk","volume":"11","author":"Vekic","year":"2023","journal-title":"Biomedicines"},{"key":"B24","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1093\/clinchem\/hvae061","article-title":"Impact of direct measurement of small dense low-density lipoprotein cholesterol for long-term secondary prevention in patients with stable coronary artery disease","volume":"70","author":"Koba","year":"2024","journal-title":"Clin Chem"},{"key":"B25","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1016\/j.jacasi.2025.04.015","article-title":"Discordance of small dense LDL cholesterol beyond LDL cholesterol or non-HDL cholesterol and carotid plaque","volume":"5","author":"Wang","year":"2025","journal-title":"JACC Asia"},{"key":"B26","doi-asserted-by":"publisher","first-page":"804214","DOI":"10.3389\/fcvm.2021.804214","article-title":"Small, dense low-density lipoprotein-cholesterol and atherosclerosis: relationship and therapeutic strategies","volume":"8","author":"Jin","year":"2021","journal-title":"Front Cardiovasc Med"},{"key":"B27","doi-asserted-by":"publisher","first-page":"3167","DOI":"10.1093\/eurheartj\/ehaf196","article-title":"Residual cholesterol and inflammatory risk in statin-treated patients undergoing percutaneous coronary intervention","volume":"46","author":"Bay","year":"2025","journal-title":"Eur Heart J"},{"key":"B28","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1093\/ehjcvp\/pvaf004","article-title":"Impact of a personalized, strike early and strong lipid-lowering approach on low-density lipoprotein-cholesterol levels and cardiovascular outcome in patients with acute myocardial infarction","volume":"11","author":"Patti","year":"2025","journal-title":"Eur Heart J Cardiovasc Pharmacother"},{"key":"B29","first-page":"10421","article-title":"The application of Gensini score and IL-1ra in assessing the condition and prognosis of patients with coronary artery disease","volume":"13","author":"He","year":"2021","journal-title":"Am J Transl Res."},{"key":"B30","doi-asserted-by":"publisher","first-page":"2311","DOI":"10.3390\/s21072311","article-title":"An automated high-accuracy detection scheme for myocardial ischemia based on multi-lead long-interval ecg and choi-williams time-frequency analysis incorporating a multi-class svm classifier","volume":"21","author":"Hussein","year":"2021","journal-title":"Sensors"}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2026.1840437\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T15:38:22Z","timestamp":1786030702000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2026.1840437\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,6]]},"references-count":30,"alternative-id":["10.3389\/fcvm.2026.1840437"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2026.1840437","relation":{},"ISSN":["2297-055X"],"issn-type":[{"value":"2297-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,6]]},"article-number":"1840437"}}